IKKβ Mediates Cell Shape-Induced Aromatase Expression and Estrogen Biosynthesis in Adipose Stromal Cells

Molecular Endocrinology

Volumn 23, Issue 5, 2009, Pages 662-670

  Ghosh, Sagar ^a   Choudary, Ahsan ^a   Ghosh, Sangeeta ^a   Musi, Nicolas ^a   Hu, Yanfen ^a   Li, Rong ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CCAAT ENHANCER BINDING PROTEIN BETA; ESTROGEN; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 3-(4-METHYLPHENYLSULFONYL)-2-PROPENENITRILE; ESTROGEN RECEPTOR; I KAPPA B KINASE; NITRILE; NONSTEROID ANTIINFLAMMATORY AGENT; PARTHENOLIDE; SESQUITERPENE; SMALL INTERFERING RNA; SULFONE;

ADIPOSE TISSUE CELL; ARTICLE; BREAST CANCER; CELL SHAPE; CONTROLLED STUDY; ESTROGEN SYNTHESIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; STROMA CELL; UPREGULATION; ADIPOSE TISSUE; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; IMMUNOBLOTTING; LENTIVIRINAE; METABOLISM; PHYSIOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ADIPOSE TISSUE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AROMATASE; CELL LINE, TUMOR; CELL SHAPE; CELL SURVIVAL; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; ESTROGENS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC VECTORS; HUMANS; I-KAPPA B KINASE; IMMUNOBLOTTING; LENTIVIRUS; NITRILES; PROMOTER REGIONS, GENETIC; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SESQUITERPENES; STROMAL CELLS; SULFONES;

EID: 66649111397     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0468     Document Type: Article

References (43)

1. Nass SJ, Davidson NE1999 Advance in breast cancer therapy. Hematol Oncol Clin North Am 13:311-332
2. Wooster R, Weber BL2003 Breast and ovarian cancer. N Engl J Med 348: 2339-2347
3. Simpson ER, Clyne C, Rubin G, Boon WC, Robertson K, Britt K, Speed C, Jones M2002 Aromatase: a brief overview. Annu Rev Physiol 64:93-127
4. Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Gurates B, Tamura M, Langoi D, Deb S2005 Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 57:359-383
5. Grodin JM, Siiteri PK, MacDonald PC1973 Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 36:207-214
6. Stoll BA2002 Upper abdominal obesity, insulin resistance and breast cancer risk. Int J Obes Relat Metab Disord 26:747-753
7. Rose DP, Komninou D, Stephenson GD2004 Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 5:153-165
8. Simpson ER, Davis SR2001 Aromatase and the regulation of estrogen biosynthesis: some new perspectives. Endocrinology 142:4589-4594
9. KamatA, HinshelwoodMM, MurryBA, MendelsonCR2002 Mechanismsin tissue-specific regulation of estrogen biosynthesis in humans. Trends Endo- crinol Metab 13:122-128
10. Bulun SE, Sebastian S, Takayama K, Suzuki T, Sasano H, Shozu M2003 The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol 86:219-224
11. Bulun SE, Price TM, Aitken J, Mahendroo MS, Simpson ER1993 A linkbetween breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin En- docrinol Metab 77:1622-1628
12. Harada N1997 Aberrant expression of aromatase in breast cancer tissues. JSteroid Biochem Mol Biol 61:175-184
13. Sasano H, Harada N1998 Intratumoral aromatase in human breast, endo- metrial, and ovarian malignacies. Endocr Rev 19:593-607
14. Meng L, Zhou J, Sasano H, Suzuki T, Zeitoun KM, Bulun SE2001 Tumor necrosis factor a and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/ enhancer binding protein a and peroxisome proliferator-activated receptor 7:mechanism of desmoplastic reaction. Cancer Res 61 2250 -2255
15. Zhou J, Gurates B, Yang S, Sebastian S, Bulun SE2001 Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein fi. Cancer Res 61:2328-2334
16. Morales L, Neven P, Paridaens R2005 Choosing between an aromatase inhibitor and tamoxifen in the adjuvant setting. Curr Opin Oncol 17:559-565
17. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ2007 Mammographic density and the risk and detection of breast cancer. N Engl J Med 356:227-236
18. Frisch SM, Screaton RA2001 Anoikis mechanisms. Curr Opin Cell Biol 13:555-562
19. Perkins ND2007 Integrating cell-signalling pathways with NF-kB and IKK function. Nat Rev Mol Cell Biol 8:49-62
20. Wang CY, Mayo MW, Baldwin Jr AS1996 TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kB. Science 274:784-787
21. Hodgson L, Henderson AJ, Dong C2003 Melanoma cell migration to type IV collagen requires activation of NF-kB. Oncogene 9:98-108
22. Chen S, Ye J, Kijima I, Kinoshita Y, Zhou D2005 Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue. JSteroid Biochem Mol Biol 95:17-23
23. Kijima I, Ye J, Glackin C, Chen S2008 CCAAT/enhancer binding protein 8 up-regulates aromatase promoters I.3/II in breast cancer epithelial cells. Cancer Res 68:4455-4464
24. Ishikawa H, Fencki V, MarshEE, YinP, Chen D, Cheng YH, Reisterd S, Lin Z, Bulun SE2008 CCAAT/enhancer binding protein β regulates aromatase expression via multiple and novel cis-regulatory sequences in uterine leiomyoma. J Clin Endocrinol Metab 93:981-991
25. PaszekMJ, Weaver VM2004 The tension mounts: mechanics meets morphogenesis and malignancy. J Mammary Gland Biol Neoplasia 9:325-342
26. Ingber DE2008 Can cancer be reversed by engineering the tumor microenvi- ronment? Semin Cancer Biol 18:356-264
27. Le Beyec J, Xu R, Lee SY, Nelson CM, Rizki A, Alcaraz J, Bissell MJ2007 Cell shape regulates global histone acetylation in human mammaryepithelial cells. Exp Cell Res 313:3066-3075
28. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, BoettigerD, HammerDA, Weaver VM2005 Tensional homeostasis and the malignant phenotype. Cancer Cell 8:241-254
29. Karin M2008 The IkB kinase: a bridge between inflammation and cancer. Cell Res 18:334-342
30. Lee DF, Kuo HP, Chen CT, Hsu JM, Chou CK, Wei Y, Sun HL, Li LY, Ping B, Huang WC, He X, Hung JY, Lai CC, Ding Q, Su JL, Yang JY, Sahin AA, Hortobagyi GN, Tsai FJ, Tsai CH, Hung MC2007 IKK/ suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130:440 -455
31. Kobayashi S, Nagino M, Komatsu S, Naruse K, Nimura Y, Nakanishi M, Sokabe M2003 Stretch-induced IL-6 secretion from endothelial cells requires NF-kB activation. Biochem Biophys Res Commun 308:306-312
32. Grimm SL, Rosen JM2003 The role of C/EBPβ in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 8:191-204
33. ChenS, ZhouD, Yang C, Okubo T, KinoshitaY, YuB, Kao YC, ItohT2001 Modulation of aromatase expression in human breast tissue. J Steroid Bio- chem Mol Biol 79:35-40
34. Deb S, Zhou J, Amin SA, Imir AG, Yilmaz MB, Lin Z, Bulun SE2006 A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters 1.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts. J Biol Chem 281:2585-2597
35. Calkhoven CF, Muller C, Leutz A2000 Translational control of C/EBPaand C/EBPβisoform expression. Genes Dev 14:1920-1932
36. Descombes P, Schibler U1991 A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569-579
37. Zahnow CA2002 CCAAT/enhancer binding proteins in normal mammary development and breast cancer. Breast Cancer Res 4:113-121
38. Gomis RR, Alarc<3n C, Nadal C, Van Poznak C, MassagueJ2006 C/EBPβat the core of the TGF β cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10:203-214
39. Katz AJ, Tholpady A, Tholpady SS, Shang H, Ogle RC2005 Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 23:412-423
40. Yue W, Brodie AM1997 Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture. J Steroid Biochem Mol Biol 63:317-328
41. ReynaSM,GhoshS,TantiwongP,MekaCS, EaganP, JenkinsonCP, Cersosimo E,Defronzo RA, ColettaDK, Sriwijitkamol A, Musi N2008 Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 57:2595-2602
42. Hu YF, Ghosh S, Amleh A, Yue W, Lu Y, Katz A, Li R2005 Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression. Oncogene 24:8343-8348
43. Ding N, Zhou H, Esteve PO, Chin HG, Kim S, Xu X, Joseph SM, Friez MJ, Schwartz CE, Pradhan S, Boyer TG2008 Mediator links epigenetic silencing of neuronal gene expression with X-linked mental retardation. Mol Cell 31:347-359